Retraction: The effects of sildenafil in maternal and fetal outcomes in pregnancy: A systematic review and meta-analysis

PLOS ONE Editors. PLoS One. 2024.

. 2024 Sep 6;19(9):e0310291.

doi: 10.1371/journal.pone.0310291. eCollection 2024.

No abstract available

Retraction of

The effects of sildenafil in maternal and fetal outcomes in pregnancy: A systematic review and meta-analysis.
Ferreira RDDS, Negrini R, Bernardo WM, Simões R, Piato S. Ferreira RDDS, et al. PLoS One. 2019 Jul 24;14(7):e0219732. doi: 10.1371/journal.pone.0219732. eCollection 2019. PLoS One. 2019. Retraction in: PLoS One. 2024 Sep 6;19(9):e0310291. doi: 10.1371/journal.pone.0310291. PMID: 31339910 Free PMC article. Retracted.

1. Ferreira RDdS, Negrini R, Bernardo WM, Simões R, Piato S (2019) The effects of sildenafil in maternal and fetal outcomes in pregnancy: A systematic review and meta-analysis. PLoS ONE 14(7): e0219732. 10.1371/journal.pone.0219732 - DOI - PMC - PubMed
1. Maher MA, Sayyed TM, Elkhouly N. Sildenafil citrate therapy for oligohydramnios: A Randomized Controlled Trial. Obstet Gynecol. 2017;129(4): 615–20. doi: 10.1097/AOG.0000000000001928 - DOI - PubMed
1. El-Sayed M. A., Saleh S. A. A., Maher M. A., & Khidre A. M. (2017). RETRACTED ARTICLE: Utero-placental perfusion Doppler indices in growth restricted fetuses: effect of sildenafil citrate. The Journal of Maternal-Fetal & Neonatal Medicine, 31(8), 1045–1050. - PubMed
1. Notice of Retraction: “Sildenafil Citrate Therapy for Oligohydramnios: A Randomized Controlled Trial” (Maher MA, Sayyed TM, and Elkhouly N). Obstetrics & Gynecology 2020;135(4): 980. doi: 10.1097/AOG.0000000000003836 - DOI - PubMed
1. Statement of Retraction: Utero-placental perfusion Doppler indices in growth restricted fetuses: effect of sildenafil citrate. (2024). The Journal of Maternal-Fetal & Neonatal Medicine, 37(1): 2360745. 10.1080/14767058.2024.2360745 - DOI - PubMed